ROIV

#579
Roivant Sciences Ltd. Common Shares
29.1200 USD
+0.59%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
29.1200
29.1200
Intervallo Annuale
18.2700
30.3300
Variazione giornaliera
+0.59%
Variazione Mensile
+2.19%
Variazione di 6 mesi
+59.04%
Variazione Annuale
+59.04%
Chiusura Precedente
28.9500
Apertura
29.1200
Bid
Ask
Minimo
29.1200
High
29.1200
Volume
171
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore 2020202120222023 TTM

Roivant Sciences Ltd

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

Notizie